Klin Onkol 2001; 14(6): 207-209.
Summary: In 1912 Paul Ehrlich included malignant diseases in the spectrum of effectivity for chemotherapy as well. But it has been found during the following development, that to differentiate normal cells from tumor ones , is chemicaly much more uneasy, comparing to the selective elimination of a microorganism from the body. Today, we understand antitumor and antibacterial chemotherapy as two different entities. But both originated from the same principles and even nowadays we are detecting situations of common influence, as in the reasearch of resistance, or discoveries of new antibiotics with antitumor activity
